‹ All Posts
Dhwani Patel

19th Mar · SEBI-Registered Analyst

AJANTPHARM
Rounding Bottom

AJANTPHARM
it is making a rounding bottom and has a very strong support at the 2,870 to 2,900 zone. The stock is relatively outperforming the broader market and once it sustains above 3,450 levels, we may see a long-term upward breakout. Since this stock is relatively outperforming, it should be on your watch list.

#Post-ClosingCommentary#TrendingSectors#HiddenGems
SmartSelect_20260319_215441_TradingView.jpg
1,155 likes·80 comments